(5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(4-phenylbutyl)octanamide

Term ID

CHEBI:166880

Synonyms

(5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(4-phenylbutyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide
(5R,6S,7S)-5,6-dihydroxy-7-octanamido-8-(alpha-D-galactosyloxy)-N-(6-phenylbutyl)octanamide
(5R,6S,7S)-8-(alpha-D-galactopyranosyloxy)-7-octanamido-5,6-dihydroxy-N-(6-phenylbutyl)octanamide
alpha-GSA[8,4P]

Definition

A synthetic alpha-galactosylsphingamide in which the galactose ring carries a (2S,3S,4R)-3,4-dihydroxy-2-(octanoylamino)-8-oxo-8-[(6-phenylbutyl)amino]octyl moiety at O-1.

References

PMID:31391251

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-galactosylsphingamide

alpha-galactosylsphingamide Show first 5 Terms
has_role: epitope

epitope Show first 5 Terms

Phenotype

Phenotype resulting from (5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(4-phenylbutyl)octanamide

Phenotype where environments contain (5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(4-phenylbutyl)octanamide

Phenotype modified by environments containing (5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(4-phenylbutyl)octanamide

Human Disease / Model Data